With the HOPE-funded extension to the facilities at the Hope Cancer Trials Centre the team at the Leicester Royal Infirmary have been able to significantly increase their ability to deliver high quality clinical trials at the centre.
Over the past year the results of trials conducted at the centre have been presented at national and international conferences.
New drugs that the Centre has studied, and which now form part of standard of care, include Sacituzumab Govitecan in triple negative breast cancer and Glofitamab in lymphoma. Both these drugs are designed to specifically target cancer cells while leaving other cells unharmed.
Hope Against Cancer originally opened a trials facility at the Leicester Royal Infirmary in 2012. In 2021 local communities, business and charitable foundations helped us raise an incredible £1.3 million to expand both the space and the opportunities that it offers to local people.
Located on the second floor of the Osborne Building at the Leicester Royal Infirmary the Hope Cancer Trials Centre provides clinical trials to people with cancer from across our region.
It is one of only a few centres conducting early-phase clinical studies outside of London and this benefits local people first as they have access to potentially life-changing treatments not yet available on the NHS.
Dr Harriet Walter Associate Professor of Medical Oncology & Director of the Hope Cancer Trials Centre
Amy King
Operations Director at the Hope Cancer Trials Centre
Nurses at the Hope Cancer Trials Centre
As well as research support Hope Against Cancer directly funds two nurses at the centre.
The Centre has an international reputation for excellence and is often chosen as a site to conduct some of the most cutting-edge treatment in the world. By participating in clinical trials people with cancer are provided with the potential to change their present and by doing so they are directly involved in building a new future for others.